Robert Berger, a 69-year-old experimenting with rapamycin, aims to enhance his health span. While he reports slight improvements, scientific backing for human longevity remains weak.
Longevity influencers tout rapamycin as a potential life-extending drug, with claims of significant mouse lifespan increases. However, human research is lacking and long-term effects are unclear.
Despite anecdotal reports of benefits from rapamycin users, such as weight loss and improved energy, the scientific understanding of its effectiveness in humans is still developing.
While rapamycin is prescribed for organ transplantation, its use for anti-aging is largely off-label, with uncertain long-term effects and limited human data available.
Collection
[
|
...
]